Avoro Capital Advisors LLC Krystal Biotech, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.65 Billion
- Q3 2024
A detailed history of Avoro Capital Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,622,222 shares of KRYS stock, worth $511 Million. This represents 7.18% of its overall portfolio holdings.
Number of Shares
2,622,222
Previous 2,433,000
7.78%
Holding current value
$511 Million
Previous $447 Million
6.73%
% of portfolio
7.18%
Previous 6.1%
Shares
11 transactions
Others Institutions Holding KRYS
# of Institutions
311Shares Held
24.4MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$769 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$555 Million0.01% of portfolio
-
State Street Corp Boston, MA1.45MShares$283 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$193 Million9.67% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$171 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...